Brief: Terns Pharmaceuticals Announces Leadership Transition
03/08/2023 23:32
Aug 3 (Reuters) - Terns Pharmaceuticals Inc TERN.O :
* TERNS PHARMACEUTICALS ANNOUNCES LEADERSHIP TRANSITION
* TERNS PHARMACEUTICALS ANNOUNCES LEADERSHIP TRANSITION
* TERNS PHARMACEUTICALS INC - SENTHIL SUNDARAM HAS RESIGNED
FROM
HIS POSITION AS TERNS' CHIEF EXECUTIVE OFFICER
* TERNS PHARMACEUTICALS INC - SUNDARAM ALSO RESIGNED FROM
BOARD OF
DIRECTORS OF TERNS BUT WILL REMAIN ON AS A SENIOR ADVISOR TO CO
* TERNS PHARMACEUTICALS INC - ERIN QUIRK WILL ASSUME
LEADERSHIP
OF COMPANY, EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:nGNX8py1VW
Further company coverage: TERN.O
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.